Literature DB >> 6561038

Staphylococcus aureus resistant to methicillin and gentamicin as a cause of outbreak of epidemic enteritis in a hospital.

F Scopetti, G Orefici, F Biondi, F Benini.   

Abstract

During the month of February 1982 in an orthopedic department (37 patients admitted), episodes of diarrhoea occurred in 9 patients, one of these resulting in the death of one patient. From the stool cultures of the patients methicillin/gentamicin resistant S. aureus (MRGRSA) was isolated. The clinical, microbiological and epidemiological analysis demonstrated the staphylococcal origin of the enterocolitis. The statistical analysis brought to light a significant increase in the acquisition of the infection in relation to age, surgical intervention, catheter, ulcers and antibiotic therapy. The medical staff, colonized at hand and nose by the epidemic strain contributed probably to the transmission from person to person. Antimicrobial therapy with oral vancomycin of colonized patients and application of topical ointment (betadine) on personnel eliminated colonization with methicillin/gentamicin resistant S. aureus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6561038

Source DB:  PubMed          Journal:  Boll Ist Sieroter Milan        ISSN: 0021-2547


  3 in total

1.  Predominant Staphylococcus aureus isolated from antibiotic-associated diarrhea is clinically relevant and produces enterotoxin A and the bicomponent toxin LukE-lukD.

Authors:  A Gravet; M Rondeau; C Harf-Monteil; F Grunenberger; H Monteil; J M Scheftel; G Prévost
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

Review 2.  Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs.

Authors:  Günter Kampf; Axel Kramer
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

3.  MRSA enteritis causing a high stoma output in the early postoperative phase after bowel surgery.

Authors:  A I Haq; L J Cook
Journal:  Ann R Coll Surg Engl       Date:  2007-04       Impact factor: 1.891

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.